Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Current Assets (2021 - 2025)

LifeStance Health (LFST) has disclosed Current Assets for 5 consecutive years, with $416.2 million as the latest value for Q4 2025.

  • Quarterly Current Assets rose 33.18% to $416.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $416.2 million through Dec 2025, up 33.18% year-over-year, with the annual reading at $416.2 million for FY2025, 33.18% up from the prior year.
  • Current Assets for Q4 2025 was $416.2 million at LifeStance Health, up from $360.4 million in the prior quarter.
  • The five-year high for Current Assets was $416.2 million in Q4 2025, with the low at $212.5 million in Q1 2023.
  • Average Current Assets over 5 years is $287.1 million, with a median of $266.5 million recorded in 2021.
  • The sharpest move saw Current Assets plummeted 32.9% in 2022, then surged 38.44% in 2024.
  • Over 5 years, Current Assets stood at $266.5 million in 2021, then decreased by 12.49% to $233.2 million in 2022, then decreased by 3.21% to $225.7 million in 2023, then soared by 38.44% to $312.5 million in 2024, then surged by 33.18% to $416.2 million in 2025.
  • According to Business Quant data, Current Assets over the past three periods came in at $416.2 million, $360.4 million, and $358.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.